Volume 27 Issue 2, February 2021
Comment | 25 January 2021
Ethical considerations of COVID-19-related adjustments to clinical research
Unexpected direct and indirect risks of participating in clinical trials have emerged during COVID-19 that investigators and institutional review boards may not be sure how to investigate. How should existing guidance and ethical frameworks for clinical trials be applied in a pandemic setting?
Nina S. Hsu, Saskia Hendriks & Christine Grady